Cancer Center

Rhabdomyosarcoma in Children

The Pediatric Surgical Oncology Program at the Cancer Center at The Children’s Hospital of Philadelphia consists of a multidisciplinary team of highly experienced and compassionate professionals who will provide expert management of your child’s rhabdomyosarcoma. In addition, many of our oncologists are actively involved in researching and developing new therapies to treat this type of cancer.

What is rhabdomyosarcoma?

Rhabdomyosarcoma in children is a rare cancer but is the most common type of sarcoma (a tumor that is malignant, or that spreads) found in soft tissues. Soft tissue includes muscles, tendons, fibrous tissues, nerves, blood vessels, fat and synovial tissues (which surround joints). Rhabdomyosarcoma begins in a type of muscle called striated muscle. The most common sites are the structures of the head and neck, the urogenital tract, and the arms and legs.

Who is diagnosed with rhabdomyosarcoma?

Most rhabdomyosarcoma cases are diagnosed in the first 10 years of life. Some children with certain birth defects are at increased risk for the disease, and some families have a gene mutation that increases risk, but the majority of children do not have any known risk factors.

What are the signs and symptoms of rhabdomyosarcoma in children?

Symptoms vary depending on the location of the tumor. Tumors in the nose or throat may cause bleeding, swallowing problems or congestion. Tumors in the vagina may visibly protrude. Bladder and vaginal tumors may cause injury or bowel obstruction. Tumors in muscle may appear as a painful lump and may be mistaken for an injury. Diagnosis is often delayed because of a lack of clear-cut symptoms or symptoms that mimic injuries. But early diagnosis is important, because rhabdomyosarcoma spreads quickly.

How do we diagnose rhabdomyosarcoma in your child?

Our physicians may:

How is rhabdomyosarcoma treated?

Surgery is the most common treatment for rhabdomyosarcoma in children. Our surgeons will remove as much of the cancer as possible, using the most advanced surgical techniques available.

Limb-sparing Orthopaedic Surgery for Pediatric Cancer

Surgical oncology specialists at CHOP are equipped to perform complex, limb-sparing surgeries for children with cancers like rhabdomyosarcoma. CHOP surgeons are constantly pushing the envelope to improve upon existing surgical techniques, and improve outcomes for patients with even the most difficult-to-treat tumors. Learn more about limb-sparing surgery in the video below.

VIDEO APPEARS HERE
 

Sometimes radiation therapy is given; this uses high-energy rays to kill cancer cells and shrink tumors. Radiation may be given before surgery or after surgery. It may be produced by a machine or by putting materials called radioisotopes through thin plastic tubes into the tumorous area. Chemotherapy (cancer medicine) is also given.

Bone marrow transplantation is another type of treatment that is being studied for recurrent rhabdomyosarcoma in children. Sometimes very high doses of chemotherapy are necessary to wipe out rhabdomyosarcoma tumors that have become resistant to standard doses. These high doses of drugs, however, can destroy the bone marrow. Before chemotherapy treatment begins, marrow is removed from the bones and stored; the marrow is then replaced. This procedure is called an autologous bone marrow transplant.

Rhabdomyosarcoma late effects/survivorship

Some children treated for pediatric cancer develop complications years later. Our Cancer Survivorship Program provides information about the potential long-term effects of the specific treatment your child received, including ways of monitoring and treating these effects.

To schedule an appointment or request a second opinion, call 267-426-0762.
You may also contact us online with comments, questions, feedback and requests for information.

  • Print
  • Share

Contact Us

Existing patients or family members, please call

215-590-3025

To schedule an initial appointment or request a 2nd opinion

267-426-0762

Cancer Clinical Trials

Search for a clinical trial